SCHEMBL27701090

SCHEMBL27701090

CC[C@H](CN=[N+]=[N-])C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ SLC1A3 P43003 2/20 0.41
▸ SLC1A2 P43004 2/20 0.41
▸ SLC1A1 P43005 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.38
▸ CHRM1 P11229 1/20 0.38
▸ AKR1A1 P14550 1/20 0.38
▸ CHRM3 P20309 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ HTR2C P28335 1/20 0.38
▸ ADRA1A P35348 1/20 0.38
▸ HRH1 P35367 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ SLC6A3 Q01959 1/20 0.38
▸ HDAC1 Q13547 1/20 0.38
▸ HDAC2 Q92769 1/20 0.38
▸ GCLC P48506 2/20 0.36
▸ USP2 O75604 1/20 0.31
▸ TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27721756 1.00 CA2 (0.42) CA2MAPK1SLC1A3SLC1A2SLC1A1
SCHEMBL15398290 0.87 CHRM1 (0.33) TDP1CHRM1AKR1A1CHRM3HTR2A
SCHEMBL19435711 0.82 CA2 (0.50) CA2MAPK1SLC1A3SLC1A2SLC1A1
SCHEMBL14252461 0.79 CPB2 (0.31) —
SCHEMBL15995454 0.79 CA2 (0.57) CA2MAPK1SLC1A3SLC1A2SLC1A1
SCHEMBL15317631 0.74 — —
SCHEMBL14704268 0.74 — —
SCHEMBL17193565 0.74 — —
SCHEMBL24982602 0.73 — —
SCHEMBL20268067 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101151265-B Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent LG LIFE SCIENCES LTD 2012-11-28 — — CN disclosed
CN-101151265-A Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent LG LIFE SCIENCES LTD (KR) 2008-03-26 — — CN disclosed
Send feedback